Message from the CEO
At Novo Genomics, we are honored to
stand at the forefront of precision medicine in Saudi Arabia
and the broader Middle East. Our journey is guided by a singular
vision: to harness the power of genomics, data science,
and next-generation biotechnology to transform healthcare
delivery, improve patient outcomes, and contribute to a
knowledge-based, innovation-driven economy.
As a Saudi-founded biotechnology company, we are deeply committed to developing solutions that are scientifically rigorous, regionally relevant, and clinically impactful. Through investments in localized research, strategic international collaborations, and cutting-edge technologies, we address critical gaps in diagnostics, preventive care, and population health—while upholding the highest standards of quality, ethics, and data integrity.
We take pride in supporting healthcare institutions, clinicians, and patients with a growing portfolio of genomic innovations that align with the Kingdom’s national priorities and the aspirations of Vision 2030. We also believe that sustained impact requires strategic collaboration—with government stakeholders, academic institutions, and the global scientific community.
At Novo Genomics, we are driven by purpose, powered by science, and inspired by the opportunity to shape the future of healthcare in the region and beyond. Thank you for your continued trust.
Dr. Abdulelah Alhawsawi
CEO, Novo Genomics